Related Experiment Video
Updated: Oct 15, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Brain atrophy trajectories predict differential functional performance in Alzheimer's disease: Moderations with
Shraddha Sapkota1, Joel Ramirez1, Vanessa Yhap1
1Hurvitz Brain Sciences Research Program Sunnybrook Research Institute Sunnybrook Health Sciences Centre Toronto Ontario Canada.
Introduction:
We examine whether distinct brain atrophy patterns (using brain parenchymal fraction [BPF]) differentially predict functional performance and decline in Alzheimer's disease (AD), and are independently moderated by (1) a key AD genetic risk marker (apolipoprotein E [APOE]), (2) sex, and (3) high-risk group (women APOE ɛ4 carriers).
Methods:
We used a 2-year longitudinal sample of AD patients (baseline N = 170; mean age = 71.3 [9.1] years) from the Sunnybrook Dementia Study. We applied latent class analysis, latent growth modeling, and path analysis. We aimed to replicate our findings (N = 184) in the Alzheimer's Disease Neuroimaging Initiative.
Results:
We observed that high brain atrophy class predicted lower functional performance and steeper decline. This association was moderated by APOE, sex, and high-risk group. Baseline findings as moderated by APOE and high-risk group were replicated.
Discussion:
Women APOE ɛ4 carriers may selectively be at a greater risk of functional impairment with higher brain atrophy.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment

